JUAN M SAAVEDRA, MD
Psychiatric at Old Georgetown Rd, Bethesda, MD
License number
Maryland D0022618
Category
Psychiatric
Type
Psychiatry
Address
Address
10401 Old Georgetown Rd, Bethesda, MD 20814
Phone
(301) 564-6320
(301) 530-4731 (Fax)
(301) 530-4731 (Fax)
Professional information
Dr. Juan M Saavedra, Bethesda MD - MD (Doctor of Medicine)
Specialties:
Psychiatry
Address:
Juan M Saavedra MD
9510 Kingsley Ave, Bethesda 20814
(301) 564-6320 (Phone)
9510 Kingsley Ave, Bethesda 20814
(301) 564-6320 (Phone)
Languages:
English
Hospitals:
Juan M Saavedra MD
9510 Kingsley Ave, Bethesda 20814
Washington Adventist Hospital
7600 Carroll Ave, Takoma Park 20912
9510 Kingsley Ave, Bethesda 20814
Washington Adventist Hospital
7600 Carroll Ave, Takoma Park 20912
Education:
Medical School
Universidad De Buenos Aires, Facultad De Ciencias Medicas
Universidad De Buenos Aires, Facultad De Ciencias Medicas
Vasoregulating Compounds And Methods Of Their Use
US Patent:
7364719, Apr 29, 2008
Filed:
Oct 3, 2003
Appl. No.:
10/529118
Inventors:
Frank Cuttitta - Adamstown MD, US
Alfredo Martinez - Bethesda MD, US
William G. Stetler-Stevenson - Kensington MD, US
Edward J. Unsworth - Kensington MD, US
Juan M. Saavedra - Bethesda MD, US
Alfredo Martinez - Bethesda MD, US
William G. Stetler-Stevenson - Kensington MD, US
Edward J. Unsworth - Kensington MD, US
Juan M. Saavedra - Bethesda MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 49/00
US Classification:
424 91, 424 111, 424 165, 424 169, 424 92
Abstract:
Methods and compounds are described for regulating blood pressure in a subject. Specific embodiments are methods for reversing vasodilation of blood vessels, by administering to a subject a therapeutically effective amount peptide AM(11-22). The vasoconstrictor can be used for a variety of purposes, including hemostasis or the treatment of shock, for example vasodilatory shock syndromes such as septic shock. Other specific embodiments are methods for reversing vasoconstriction of blood vessels, by administering to a subject a therapeutically effect amount of an inhibitor of AM(11-22), sufficient to reduce hypertension in the subject. Compounds and pharmaceutical compositions are also provided, as are kits.